Chk1 inhibition enhances cisplatin cytotoxicity and overcomes cisplatin resistance in small cell lung cancer by promoting mitotic cell death

INTRODUCTION: Platinum-based chemotherapy remains the standard treatment for patients with small cell lung cancer (SCLC), but the benefit of the treatment is often hampered by rapid development of drug resistance. Thus far, there is no targeted therapy available for SCLC. Over 90% of SCLC tumors har...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Oncol
Main Authors: Hsu, Wei-Hsun, Zhao, Xiaoliang, Zhu, Jianquan, Kim, In-Kyu, Rao, Guanhua, McCutcheon, Justine, Hsu, Shuo-Tse, Teicher, Beverly, Kallakury, Bhaskar, Dowlati, Afshin, Zhang, Yu-Wen, Giaccone, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534433/
https://ncbi.nlm.nih.gov/pubmed/30771522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2019.01.028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados